Cancer BiologybioRxivPreprint
Evolutionary exploitation of PD-L1 expression in hormone receptor positive breast cancer
Jeffrey West, Derek Park, Cathal Harmon…·Mark Robertson-Tessi
The paper models how timing of aromatase inhibitor and immune checkpoint inhibitor therapies affects tumor burden and metastatic potential in hormone receptor positive breast cancer.
DOI 10.1101/454447